<SEC-DOCUMENT>0001140361-21-028702.txt : 20210818
<SEC-HEADER>0001140361-21-028702.hdr.sgml : 20210818
<ACCEPTANCE-DATETIME>20210817173427
ACCESSION NUMBER:		0001140361-21-028702
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210817
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210818
DATE AS OF CHANGE:		20210817

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tilray, Inc.
		CENTRAL INDEX KEY:			0001731348
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				824310622
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38594
		FILM NUMBER:		211184217

	BUSINESS ADDRESS:	
		STREET 1:		655 MADISON AVENUE
		STREET 2:		19TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10065
		BUSINESS PHONE:		519.322.8800

	MAIL ADDRESS:	
		STREET 1:		655 MADISON AVENUE
		STREET 2:		19TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10065
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10028155_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:tlry="http://tilray.com/20210817" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial Disclosure, LLC
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2021 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_662f1afd92eb412583661328188fc2eb" contextRef="c20210817to20210817" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_775a0ecbf5bf49fa9a7be35c0e05a145" contextRef="c20210817to20210817">19th Floor</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_667bfbb2916244f881e4e80a7eed5245" contextRef="c20210817to20210817">19th Floor</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_4e7762a866644492b804bc17473dabb3" contextRef="c20210817to20210817">0001731348</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="tlry-20210817.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20210817to20210817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001731348</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-17</xbrli:startDate><xbrli:endDate>2021-08-17</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  <div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_9412a30cc0804e97aef8aec7c1954084" contextRef="c20210817to20210817">8-K</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECURITIES EXCHANGE ACT OF 1934</div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported): <span style="font-weight: bold;"><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_fb59b99a10df4d8d982fac20368a6b87" contextRef="c20210817to20210817" format="ixt:datemonthdayyearen">August 17, 2021</ix:nonNumeric></span></div>

    <div>&#160;</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_508b94f36f0846e08d7d500b6dc60261" contextRef="c20210817to20210817">Tilray, Inc.</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_081a56ab4ba3461fabd067e4931571b3" contextRef="c20210817to20210817" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </div>
          </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_14795004a4634d1797c57b90a0002c58" contextRef="c20210817to20210817">001-38594</ix:nonNumeric><br />
              </div>
            </div>
          </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_60cf05b182664a7fa600388358607941" contextRef="c20210817to20210817">82-4310622</ix:nonNumeric><br />
              </div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(State or other jurisdiction of incorporation)</div>
          </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Commission File Number)</div>
          </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_b743c091c3bd44fcbc1cc2fa2b00fa46" contextRef="c20210817to20210817">655 Madison Avenue</ix:nonNumeric>,
      <span style="-sec-ix-hidden:Fact_667bfbb2916244f881e4e80a7eed5245">19th Floor</span>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_1e7af5b3e9684945a2467da862ae0aff" contextRef="c20210817to20210817">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_09a4748da99a4e4b9b454592e7082398" contextRef="c20210817to20210817" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_af135b5bab5646b5871aed5ce1206c73" contextRef="c20210817to20210817">10065</ix:nonNumeric></div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Address of principal executive offices, including zip code)</div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code:<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_75a6ed0735d44237a5276b0a12fc909e" contextRef="c20210817to20210817">519</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_fe6dfcac64c64cb9ba50732e9de83704" contextRef="c20210817to20210817">322-8800</ix:nonNumeric></span></div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

    <div>&#160;</div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
      any of the following provisions:</div>

    <div>&#160;</div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_626d0b3ccdea4a548b8e799d938cb3f7" contextRef="c20210817to20210817" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div>&#160;</div>

    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_605625b016ec4583a8f20f5ea0170478" contextRef="c20210817to20210817" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="vertical-align: top; width: auto;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
    </div>

    <div>&#160;</div>

    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_00cfa7ff4cd94fa8846b0bbd0f607a79" contextRef="c20210817to20210817" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
              </div>
            </td>

    <td style="vertical-align: top; width: auto;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
    </div>

    <div>&#160;</div>

    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_3bf4f3257ce74dd78b6f8a562fb53050" contextRef="c20210817to20210817" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="vertical-align: top; width: auto;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
    </div>

    <div>&#160;</div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 33%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Title of each class</div>
            </div>
          </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trading Symbol(s)</div>
            </div>
          </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 33%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Name of each exchange on which</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> registered</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_1a83fda4376947d4a662f1520c629dec" contextRef="c20210817to20210817">Class 2 Common stock, par value $0.0001 per share</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_ccd2d5b943cf4db88eb8cafc8d65517e" contextRef="c20210817to20210817">TLRY</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_f87ca5a4760b494f94c1db9a527c5f90" contextRef="c20210817to20210817" format="ixt-sec:exchnameen">The NASDAQ Global Select Market</ix:nonNumeric><br />
            </div>
          </td>

  </tr>


</table>
    <div>&#160;</div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;
      230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</div>

    <div>&#160;</div>

    <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_c1975ab06d07428aa05f8eb977037a07" contextRef="c20210817to20210817" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div>&#160;</div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
      with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

    <div>&#160;</div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <!--PROfilePageNumberReset%Num%1%%%-->
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Entry into a Material Definitive Agreement</div>
          </td>

  </tr>


</table>
    <div>&#160;</div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tilray, Inc. (&#8220;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Tilray</span>&#8221;) and certain
      strategic investors formed a new Delaware limited partnership, Superhero Acquisition L.P. (&#8220;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Acquisition Co.</span>&#8221;), for the sole purpose of acquiring
      approximately US$165.8 million principal amount of senior secured convertible notes (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Notes</span>&#8221;) originally issued by MedMen Enterprises Inc. (&#8220;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">MedMen</span>&#8221;) and certain warrants (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants</span>&#8221;) to
      acquire Class B subordinate voting shares (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">MedMen Shares</span>&#8221;)<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</span>issued in connection with the original issuance of the Notes.&#160; Pursuant to an Assignment and Assumption Agreement dated as of August 17, 2021, Acquisition Co. completed its acquisition (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Transaction</span>&#8221;)<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</span>of the Notes and Warrants <span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">from certain funds affiliated with Gotham Green Partners (collectively, &#8220;</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">GGP</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;).</span></div>

    <div><br />
    </div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">As consideration for the
        Notes and Warrants, subject to Tilray receiving the requisite stockholder approval necessary to increase the number of shares of its authorized capital stock (the &#8220;</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Requisite Approval</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;), Tilray will issue approximately 9.0 million
        shares of its common stock (the &#8220;</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Consideration Shares</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;) to GGP.&#160; In the event that Tilray does not obtain the Requisite Approval necessary for the issuance of the Consideration Shares prior to December 1, 2021, GGP may elect to receive cash
        in lieu of the Consideration Shares.</span></div>

    <div><br />
    </div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">Tilray also agreed to
        provide GGP with customary resale registration rights in respect of the Consideration Shares and provided GGP with the potential to receive additional Consideration Shares in the event that the per-share closing price of Tilray&#8217;s outstanding common
        stock (the &#8220;</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Reference Price</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;) on the trading day immediately preceding the earlier of (i) the date that the registration statement regarding the resale of the Consideration Shares is declared effective and (ii) December 1, 2021, is
        less than the Reference Price on the trading day immediately preceding the public announcement of the Transaction.</span></div>

    <div><br />
    </div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #FEFEFE;">Prior to Acquisition Co&#8217;s purchase of the Notes and Warrants, MedMen entered into certain
        amendments to these securities with GGP to facilitate Acquisition Co.&#8217;s acquisition of its interest in these securities in compliance with applicable securities laws and stock exchange rules.&#160; As a result of the Transaction, Tilray indirectly
        acquired a right to 68% of the Notes and the Warrants held by Acquisition Co, representing an interest of approximately 21% of the outstanding MedMen Shares on the closing date of the Transaction (assuming such Notes and Warrants were converted and
        exercised upon closing the Transaction).&#160; Acquisition Co. was also granted &#8220;top-up&#8221; rights enabling it (and its limited partners) to maintain its percentage ownership (on an &#8220;as-converted&#8221; basis) in the event that MedMen issues equity securities
        upon conversion of convertible securities that may be issued by MedMen.</span></div>

    <div><br />
    </div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">The Notes and Warrants may
        be exercised by Acquisition Co. (or Tilray if Tilray elects to have the Notes and/or Warrants it beneficially owns distributed from Acquisition Co.) following the date that the federal laws in the United States are amended to permit the general
        cultivation, distribution and possession of cannabis or to remove the regulation of such activities from the federal laws of the United States (a &#8220;</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Triggering Event</span><span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;) or upon Tilray&#8217;s waiver of a Triggering Event, subject to the provisions
        of the Notes and Warrants and the agreements related thereto.</span></div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 3.02</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unregistered Sales of Equity Securities.</div>
          </td>

  </tr>


</table>
    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> </span><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The disclosure in Item 1.01 of this Form 8-K is incorporated into this Item 3.02 by reference.</div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Consideration Shares issuable upon receipt of <span style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">the requisite stockholder approval necessary to increase the number of shares of its authorized capital stock</span> will be issued in reliance on the exemption provided by Section 4(a)(2) of the Securities Act for the
      offer and sale of securities not involving a public offering.</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Exhibits.</div>
            </td>

  </tr>


</table>
    </div>

    <div>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><br />
      </div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
            <div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
            </div>
          </td>

    <td style="width: 3%; vertical-align: bottom;">&#160;</td>

    <td style="width: 92%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit Description</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle;">&#160;</td>

    <td style="width: 3%; vertical-align: middle;">&#160;</td>

    <td style="width: 92%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10028155_ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 3%; vertical-align: bottom;">&#160;</td>

    <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Press release dated August 17, 2021</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">1</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

    <div><br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
      signed on its behalf by the undersigned hereunto duly authorized.</div>

    <div>&#160;</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: top;" colspan="2">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TILRAY, INC.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Dated: August 17, 2021</div>
          </td>

    <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
          </td>

    <td style="width: 50%; vertical-align: top; border-bottom: 2px solid black;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">/s/ Mitchell Gendel</div>
          </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Name:</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Mitchell Gendel</div>
          </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Title:</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Global General Counsel</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

  </div>

  <div><br />
  </div>

  <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">2</span></div>

  <div style="text-align: center;" class="DSPFPageNumberArea">
    <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10028155_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial Disclosure, LLC
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 70%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;" id="z75fc3bfeeada47ff8e6caade74021e15">

        <tr>
          <td style="width: 35%; text-align: center;"><img src="image00002.jpg"></td>
          <td style="width: 35%; text-align: center;"><img src="image00003.jpg"></td>
        </tr>

    </table>
  </div>
  <div><br>
    <div style="text-align: center; margin-right: 18pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TILRAY ACQUIRES MAJORITY POSITION IN AMENDED MEDMEN CONVERTIBLE NOTES</div>
    <div><br>
    </div>
    <div style="text-align: center; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Investment Provides Tilray a Potential Accelerated Path into U.S. Cannabis Market Upon Federal Legalization</div>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Amendment and Extension of Convertible Notes Enables MedMen to Reshape Balance Sheet and Further Accelerate its Growth Trajectory</div>
    <div>&#160;</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Tilray and MedMen CEOs to Host a Conference Call and Webcast at 5:00 PM Eastern Time</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">NEW YORK and LOS ANGELES &#8211; August 17, 2021 </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#8212;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Tilray, Inc. (&#8220;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Tilray</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#8221;) (Nasdaq l TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, and </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">MedMen Enterprises Inc. (&#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">MedMen</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#8221;) (CSE: MMEN) (OTCQX: MMNFF), a premier American cannabis retailer, </font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">today announced that Tilray has </font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">acquired the majority of the outstanding senior secured convertible notes (the &#8220;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Notes</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;) of MedMen that were originally held</font><font style="background-color: #FEFEFE; font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> by </font><a name="z_cp_text_1_1"></a><font style="background-color: #FEFEFE; font-size: 10pt; font-family: 'Times New Roman', Times, serif;">certain funds affiliated with
        Gotham Green Partners</font><a name="z_cp_text_1_3"></a><font style="background-color: #FEFEFE; font-size: 10pt; font-family: 'Times New Roman', Times, serif;">,</font> LLC <font style="background-color: #FEFEFE; font-size: 10pt; font-family: 'Times New Roman', Times, serif;">and other funds</font> <font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">(collectively, &#8220;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">GGP</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;). The acquisition </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">provides Tilray with a path, subject to necessary regulatory approvals, to obtain a significant equity position in MedMen through conversion of the Notes and exercise of associated warrants (the &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Warrants</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#8221;) </font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">following U.S. cannabis legalization (or Tilray&#8217;s waiver of such condition).In connection with the sale of the Notes, MedMen and GGP amended the restrictive covenants and extended the
        debt maturity to 2028 to provide MedMen the flexibility to execute on its growth priorities and explore additional strategic opportunities. In addition, MedMen separately announced today a significant equity investment from a private placement of
        MedMen Shares (as defined below) and warrants to a group of investors.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><font style="background-color: #FEFEFE;">MedMen is a leading cannabis retail brand in the U.S., holding 21 licenses and 25 retail locations across
        key urban centers, including the Bay Area, Los Angeles, Boston, Chicago, and Las Vegas, and a significant position in California, the world&#8217;s largest market. Prior to U.S. federal legalization of cannabis, and subject to compliance with applicable
        laws and stock exchange rules, MedMen will actively explore opportunities to expand MedMen&#8217;s footprint across international markets.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Irwin D. Simon, Tilray&#8217;s Chairman and CEO,
        said, &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(28, 29, 32);">Backed by accelerating trends towards legalization globally, we are focused on building the world's leading cannabis-focused consumer branded
        company with a goal of $4 billion of revenue by the end of our fiscal 2024. The investment we are announcing in MedMen securities today, one of the most recognized brands in the $80 billion U.S. cannabis market, is a critical step towards
        delivering on our objective as we work to enable Tilray to lead the U.S. market when legalization allows.&#8221;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(28, 29, 32);">Mr. Simon</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> continued, &#8220;Our ability to maximize value from this game-changing transaction rests on the support of our shareholders at the upcoming Special Meeting to vote on our Authorized Shares
        Proposal, which will increase the number of authorized shares Tilray has available to not only complete this transaction, but also to execute on other strategic acquisitions.&#160; I cannot stress enough the importance of making our shareholders&#8217; voices
        count to enable us to maximize our potential to create substantial value for our shareholders in the near-term and in the future.&#8221;</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="background-color: #FEFEFE;">
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">Tom Lynch, MedMen&#8217;s Chairman and CEO, added, &#8220;</font><font style="background-color: rgb(255, 255, 255); font-size: 10pt; font-family: 'Times New Roman';">Our management team has spent the past 18 months executing a disciplined turnaround plan. We are grateful to our stakeholders for their patience and
          support as we worked to fix the business and rebuild trust and credibility. We believe that patience has paid off, as these efforts have succeeded in attracting partners who share our vision for building the world&#8217;s most powerful cannabis retail
          brand. </font>In addition, the proceeds from the private placement and amendments to the Notes, <font style="background-color: rgb(255, 255, 255); font-size: 10pt; font-family: 'Times New Roman';">gives MedMen the cash and flexibility to match
          our revenue trajectory to our operational expertise and internationally renowned brand. MedMen 2.0 is here, and we are thrilled to embark on the next stage of our journey</font>.&#8221;</div>
      <div>&#160;</div>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="background-color: #FEFEFE;">Transaction Overview</font></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Under the terms of the transaction, a newly
        formed limited partnership (the &#8220;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">SPV</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#8221;) established by Tilray and other strategic investors acquired an aggregate principal amount of approximately U.S.$165.8 million of the Notes and the Warrants, all of which
        were originally issued by MedMen and held by GGP, representing 75% of the outstanding Notes and 65% of the outstanding Warrants. </font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">Tilray&#8217;s
        interest in the SPV represents rights to 68% of the Notes and related Warrants held by the SPV, which are convertible into, and exercisable for, approximately 21% of the outstanding Class B subordinate voting shares of MedMen (the &#8220;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">MedMen Shares</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;) upon
        closing of the transaction.&#160; Tilray&#8217;s ability to convert the Notes and exercise the Warrants is dependent upon</font>&#160;<font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">U.S. federal legalization of
        cannabis or Tilray&#8217;s waiver of such requirement as well as any additional regulatory approvals.&#160; </font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">As consideration for
        Tilray&#8217;s interest in the Notes and Warrants, and subject to Tilray receiving the stockholder approval necessary to increase the number of shares of its authorized capital stock, Tilray will issue approximately 9.0 million shares of its common stock
        to GGP; </font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-style: italic; color: rgb(0, 0, 0);">provided, however</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, that if Tilray has not received the stockholder approval by December 1, 2021, GGP may elect to receive cash rather than Tilray shares. Tilray&#8217;s previously scheduled Special Meeting of
        Stockholders will be held this Thursday, August 19, 2021.&#160; </font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">MedMen did not receive any proceeds from the transfer of the Notes.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">In connection with the transactions, the parties agreed to amend and
        restate (the &#8220;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Amendment and Restatement</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;) the facility governing the Notes (the &#8220;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Facility</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;)</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">to, among other things, extend the maturity date to August 16, 2028, eliminate any cash interest obligations and instead provide for pay-in-kind interest, eliminate certain repricing
        provisions, and eliminate and revise certain restrictive covenants. Accrued pay-in-kind interest on the Notes will be convertible at price equal to the trailing 30-day volume weighted average price of the MedMen Shares, as and when such pay-in-kind
        interest becomes due and payable, subject to the maximum permitted discount under the rules of the Canadian Securities Exchange.&#160; The Notes held by holders on the date of the amendment and restatement may not be prepaid by MedMen until legalization
        of the general cultivation, distribution and possession of marijuana at the federal level in the United States or the removal of the regulation of such activities from the U.S. federal laws. Any such prepayment shall require at least six months&#8217;
        notice.&#160; If Notes are transferred following the date of the amendment and restatement (the &#8220;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">effective date</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">&#8221;), such Notes may not be prepaid until the earlier of the third anniversary of the effective date or 90 days following the transfer of such Notes to
        such holders. Transfers of Notes will be permitted subject only to notice and compliance with securities laws. The Notes will also provide the holders of the Notes with a top-up right to acquire additional MedMen Shares and a pre-emptive right with
        respect to future financings of the Company, subject to certain exceptions, upon the issuance by MedMen of certain equity or equity-linked securities. No changes have been made to the conversion and exercise prices of the Notes or related Warrants.</font></div>
    <div>&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which
      such offer, solicitation or sale would be unlawful. The securities being offered have not been registered under the United States Securities Act of 1933, as amended (the &#8220;U.S. Securities Act&#8221;), and may not be offered or sold in the United States
      absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act, and applicable state securities laws. The MedMen has agreed to provide customary registration rights to holders of the Notes with respect to
      the MedMen Shares underlying the Notes and related Warrants and the investors in the private placement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">For further transaction details, investors and security holders may obtain a copy of the presentation
        associated with the transaction on the MedMen website at </font><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>https://investors.medmen.com</u></font><font style="font-size: 10pt; font-family: 'Times New Roman';"> and on the
        investor page of Tilray&#8217;s website at </font><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>https://ir.tilray.com</u></font><font style="font-size: 10pt; font-family: 'Times New Roman';">.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Conference Call</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tilray and MedMen will host a conference call to discuss today&#8217;s announcement at 5:00 p.m. ET. Investors interested in participating in the live
      call can dial (877) 458-4121 from Canada and the U.S. or (323) 794-2597 from international locations.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">There will also be a simultaneous, live webcast available on the Investors section of the Company&#8217;s website at <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>www.tilray.com</u></font>. The webcast will also be archived after the call concludes.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Advisors</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Moelis &amp; Company LLC is serving as exclusive financial advisor to MedMen. Weil, Gotshal &amp; Manges LLP, Cassels Brock &amp; Blackwell LLP and
      Manatt, Phelps &amp; Phillips, LLP are serving as legal counsel to MedMen. DLA Piper LLP (U.S.) and DLA Piper (Canada) LLP acted as legal counsel to Tilray. Davies Ward Phillips &amp; Vineberg LLP acted for Serruya Private Equity. Canaccord Genuity
      Corp. is serving as exclusive financial advisor to Gotham Green. KTBS Law, LLP, Honigman, LLP, Stubbs Alderton &amp; Markiles, LLP and SkyLaw Professional Corporation acted as legal <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">counsel to Gotham Green.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Tilray, Inc.</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tilray, Inc. is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe,
      Australia, and Latin America that is changing people's lives for the better &#8211; one person at a time &#8211; by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind,
      body, and soul and invoke a sense of wellbeing. Tilray&#8217;s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and
      innovative products.&#160; A pioneer in cannabis research, cultivation, and distribution, Tilray&#8217;s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic
      beverages.</div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </font><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">For more information on how we open a world of wellbeing, visit </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">www.Tilray.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About MedMen</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">MedMen is a premier American cannabis retailer with an operational footprint in
        California, Nevada, Illinois, Arizona, Massachusetts, and Florida. MedMen offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red and LuxLyte through its premium retail stores, proprietary delivery service, as
        well as curbside and in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier, and
        happier. Learn more about MedMen at </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">www.medmen.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Early Warning Reporting Matters</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Pursuant to the Transaction, Tilray, located at </font><font style="font-size: 10pt; font-family: 'Times New Roman';">655 Madison Ave., New York, New York 10065, acquired beneficial ownership or control or direction over Notes in the principal amount of U.S.$165.8 million and Warrants to acquire approximately 135.3 million MedMen
        Shares held by the SPV. If the Notes were converted and the Warrants exercised immediately following the completion of the Transaction, the SPV would control 940.5 million MedMen Shares and Tilray would hold beneficial ownership of approximately
        639.5 million MedMen Shares.&#160; In addition to Tilray&#8217;s interests in the Notes and Warrants, as a holder of Notes, the SPV (in which Tilray has a 68% beneficial ownership) has certain top-up rights from MedMen, which will enable the SPV to subscribe
        for additional MedMen Shares to maintain its proportionate ownership of MedMen, subject to certain issuances excluded from the top-up rights, and will enable Tilray to maintain its proportionate beneficial interest in MedMen.&#160; The SPV's acquisition
        of the purchased Notes and Warrants, and Tilray&#8217;s beneficial ownership of such securities, requires the disclosure included in this press release under the heading &#8220;Early-Warning Reporting Matters&#8221; and the filing of an early warning report (the &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Early Warning Report</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8221;) for purposes of National Instrument 62-103 - </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">The Early Warning System and Related Take-Over Bid and Insider Reporting Issues</font><font style="font-size: 10pt; font-family: 'Times New Roman';">.&#160; A copy of the Early Warning Report
        will be filed under MedMen&#8217;s profile on www.SEDAR.com.</font></div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </font><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Tilray&#8217;s interests in the Notes and Warrants were acquired</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> by Tilray for investment purposes and its strategic rationale described in this press release. In accordance with applicable securities laws and subject to applicable stock exchange
        requirements, Tilray may from time to time and at any time, directly or otherwise, increase or decrease its ownership, control or direction of MedMen Shares and Tilray and the SPV each reserves the right to acquire or dispose of any or all of the
        Notes, Warrants, top-up related securities or any MedMen Shares received on conversion or exercise thereof in accordance with applicable securities laws.&#160; Tilray&#8217;s and the SPV&#8217;s determination may be driven by market conditions, future strategic
        planning, the business and prospects of the MedMen and any other factors that Tilray or the SPV, as applicable, may consider relevant from time to time.&#160; </font></div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Related Party Transaction</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">The Amendment and Restatement, including the issuance of the top-up right and the pre-emptive right, are
        considered to be "related party transactions" under Multilateral Instrument 61-101 &#8211; Pr</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">otection of Minority Security Holders in Special Transactions</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> (&#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">MI 61-101</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8221;) insofar as they
        involve GGP and Parallax Master Fund LP. Both GGP and its controlled funds, and Parallax Master Fund LP and its controlled funds, are related parties (as defined in MI 61-101) to MedMen and lenders under the Facility. Unless there is an exemption,
        MedMen would ordinarily be required to obtain a formal valuation and "minority approval", being approval of disinterested shareholders of MedMen, with respect to the Amendment and Restatement. As reported in MedMen's Unaudited Interim Condensed
        Consolidated Financial Statements for the Nine Months Ended March 27, 2021 and March 28, 2020, MedMen's accumulated deficit and a negative net working capital (current liabilities greater than current assets) as of March 26, 2021, as well as a net
        loss and negative cash flow from operating activities for the reporting period then ended raise substantial doubt about MedMen's ability to continue as a going concern. MedMen is relying on the exemption from obtaining a formal valuation available
        in section 5.5(b) of MI 61-101 and the exemption from obtaining minority approval available in section 5.7(e) of MI 61-101. MedMen meets the requirements set out section 5.5(b) of MI 61-101 because the Shares are only traded on the facilities of
        the Canadian Securities Exchange. MedMen meets the requirements set out in section 5.7(e) of MI 61-101 based on the board of directors of MedMen, acting in good faith, having determined, and MedMen's independent directors (being all the directors),
        acting in good faith, unanimously having determined that MedMen is in serious financial difficulty, that the Amendment and Restatement are designed to improve MedMen's financial position, and that the Amendments are reasonable in MedMen's
        circumstances. The material change report for the Amendment and Restatement will not be filed more than 21 days prior to closing, as the transactions that constitute the related party transaction were effectively closed upon of execution of the
        Amendment and Restatement, and until execution, there was no material change that could be disclosed.</font></div>
    <div>&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="background-color: #FEFEFE;">Cautionary Statement Concerning Forward-Looking Statements</font></div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">Certain statements contained in this press
        release constitute "forward-looking statements" within the</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman';">meaning of federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictions based on expectations and projections about future
        events and are not statements of historical fact. You can identify forward-looking statements by the use of forward-looking terminology such as "plan," "continue," "expect," "anticipate," "intend," "predict," &#8220;believe,&#8221; "project," "estimate,"
        "likely," "believe," "might," "seek," "may," "will," "remain," "potential," "can," "should," "could," "future", &#8220;is positioned&#8221; and similar expressions, or the negative of those expressions, or similar words or phrases that are predictions of or
        indicate future events or trends and that do not relate solely to historical matters. You can also identify forward-looking statements by discussions of the Tilray&#8217;s or MedMen&#8217;s strategic initiatives, including productivity and synergies
        initiatives, our future performance and results of operations.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Forward-looking statements involve known and
        unknown risks, uncertainties and other factors which may cause the actual results, levels of activity, performance or achievements of </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Tilray or MedMen</font><font style="background-color: rgb(254, 254, 254); font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, or industry results, to be materially different from any future results, levels of activity, performance or achievements expressed
        or implied by such forward-looking statements, and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods that may be incorrect or imprecise and may not be able to be realized.
        We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Forward-looking statements
        include statements regarding intentions, beliefs, projections, outlook, analyses, or current expectations for the Tilray or MedMen business; the legalization of cannabis under U.S. federal laws and Tilray&#8217;s ability to become </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(28, 29, 32);">the world's leading cannabis-focused consumer branded company with $4 billion of revenue by 2024</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">; and Tilray&#8217;s receipt of stockholder approval to increase its authorized capital stock. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the
        forward-looking statements throughout this communication. Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to
        Tilray or MedMen, as applicable, or that Tilray or MedMen, as applicable, deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed
        discussion of these risks and other factors, see the Annual Report on Form 10-K of Tilray for the fiscal year ended May 31, 2021. The forward-looking statements included in this communication are made as of the date of this communication and MedMen
        does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">A variety of factors, including known and unknown risks, many of which are beyond the
        control of Tilray or MedMen, could cause actual results to differ materially from the forward-looking statements in this press release and other reports filed with, or furnished to, the SEC and other regulatory agencies by Tilray or MedMen and made
        by the directors, officers, other employees, and other persons authorized to speak on behalf of Tilray or MedMen. Such factors include, without limitation: (i) if, when and to the extent cannabis is legalized at the federal level in the United
        States; (ii) the ability of either company to effectively grow and expand retail operations in the United States;&#160; (iii) ability to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic; (iv) the
        respective management teams&#8217; perceptions of historical trends, current conditions and expected future developments; (v) the ability to effectively manage growth, including anticipated and unanticipated costs; (vi) achieving the anticipated results
        of the Tilray or MedMen's strategic plans, including growing market share; (vii) the adequacy of each company&#8217;s capital resources and liquidity, including but not limited to, availability of sufficient cash flow to successfully execute their
        respective growth strategies (either within the expected timeframe or at all); (viii) the ability to raise necessary or desired funds to achieve their respective strategic business plans; (ix) obtaining and maintaining all required licenses,
        approvals and permits; (x) favorable production levels and sustainable costs; (xi) inputs, suppliers and skilled labor being unavailable or available only at uneconomic costs; (xii); (xiii) adverse future legislative and regulatory developments
        involving medical and recreational marijuana; (xiv) consumer interest in the companies&#8217; respective products and products of other brands that MedMen may offer in its stores; (xv) competition; (xvi) government regulation of either company&#8217;s
        activities and products including, but not limited, to the areas of taxation and environmental protection; (xviii) the risks of operating or investing in the marijuana industry in the United States; (xviii) the outcome of any claims, litigation and
        proceedings of which either company is a party, including any settlements of litigation or pending regulatory or government investigations or actions or other legal contingencies; (xix) either company&#8217;s ability to conduct operations in a safe,
        efficient and effective manner; (xx) changes in general economic, business and political conditions in which the companies operate, including changes in the financial markets; changes in applicable laws generally and (xxi) and those other risk
        factors discussed in MedMen&#8217;s Form 10 (as amended) or in the risk factors discussed in Tilray&#8217;s Annual Report on Form 10-K, and other continuous disclosure filings, all available under either at </font><u>www.sec.gov</u><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> (with respect to both MedMen and Tilray) or www.sedar.com (solely with respect to MedMen).</font></div>
    <div><br>
    </div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Tilray Media Contact</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Berrin Noorata, </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">news@tilray.com</font></u></div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </font><br>
    </div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Tilray Investor Relations</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Raphael Gross, </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">Raphael.Gross@icrinc.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, +1-203-682-8253</font></div>
    <div><br>
    </div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MedMen Media Contact</div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Lisa Weser, </font><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>MedMen@Trailblaze.co</u></font></div>
    <div><br>
    </div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MedMen Investor Relations Contact</div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Morry Brown, morry.brown@MedMen.com</div>
    <div><br>
    </div>
  </div>
  <div><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>tlry-20210817.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://tilray.com/20210817" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:tlry="http://tilray.com/20210817" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="tlry-20210817_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tlry-20210817_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://tilray.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>tlry-20210817_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>tlry-20210817_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://tilray.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="tlry-20210817.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tilray.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  X -<# 2(  A$! Q$!_\0
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MUMP0#)*X503TY-0DV[(HM45SW_";>%_^A@TO_P "4_QH'C7PP3C_ (2#2_\
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A110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  Z +X# 2(  A$! Q$!_\0
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M*WK?3\C#^&__ ""?&G_8&D_]#2N/T^[EL+^VN[<[9K>194/HRG(_E78?#?\
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M)P@CEPF+EB*%>O+^K(XS0=)N]=U>VTW3U5KJX8K&&;:"0">OX5W/_"E_&/\
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=V9E1DZ/T/U<_RKO:**<81@K11-:O4KRYJCNS_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>brhc10028155_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tlry-20210817.xsd" xlink:type="simple"/>
    <context id="c20210817to20210817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001731348</identifier>
        </entity>
        <period>
            <startDate>2021-08-17</startDate>
            <endDate>2021-08-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20210817to20210817"
      id="Fact_662f1afd92eb412583661328188fc2eb">false</dei:AmendmentFlag>
    <dei:EntityAddressAddressLine2
      contextRef="c20210817to20210817"
      id="Fact_775a0ecbf5bf49fa9a7be35c0e05a145">19th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine2
      contextRef="c20210817to20210817"
      id="Fact_667bfbb2916244f881e4e80a7eed5245">19th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityCentralIndexKey
      contextRef="c20210817to20210817"
      id="Fact_4e7762a866644492b804bc17473dabb3">0001731348</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20210817to20210817"
      id="Fact_9412a30cc0804e97aef8aec7c1954084">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20210817to20210817"
      id="Fact_fb59b99a10df4d8d982fac20368a6b87">2021-08-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20210817to20210817"
      id="Fact_508b94f36f0846e08d7d500b6dc60261">Tilray, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20210817to20210817"
      id="Fact_081a56ab4ba3461fabd067e4931571b3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20210817to20210817"
      id="Fact_14795004a4634d1797c57b90a0002c58">001-38594</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20210817to20210817"
      id="Fact_60cf05b182664a7fa600388358607941">82-4310622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20210817to20210817"
      id="Fact_b743c091c3bd44fcbc1cc2fa2b00fa46">655 Madison Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20210817to20210817"
      id="Fact_1e7af5b3e9684945a2467da862ae0aff">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20210817to20210817"
      id="Fact_09a4748da99a4e4b9b454592e7082398">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20210817to20210817"
      id="Fact_af135b5bab5646b5871aed5ce1206c73">10065</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20210817to20210817"
      id="Fact_75a6ed0735d44237a5276b0a12fc909e">519</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20210817to20210817"
      id="Fact_fe6dfcac64c64cb9ba50732e9de83704">322-8800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20210817to20210817"
      id="Fact_626d0b3ccdea4a548b8e799d938cb3f7">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20210817to20210817"
      id="Fact_605625b016ec4583a8f20f5ea0170478">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20210817to20210817"
      id="Fact_00cfa7ff4cd94fa8846b0bbd0f607a79">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20210817to20210817"
      id="Fact_3bf4f3257ce74dd78b6f8a562fb53050">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20210817to20210817"
      id="Fact_1a83fda4376947d4a662f1520c629dec">Class 2 Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20210817to20210817"
      id="Fact_ccd2d5b943cf4db88eb8cafc8d65517e">TLRY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20210817to20210817"
      id="Fact_f87ca5a4760b494f94c1db9a527c5f90">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20210817to20210817"
      id="Fact_c1975ab06d07428aa05f8eb977037a07">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140675290859496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 17, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 17,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Tilray, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-4310622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">655 Madison Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">19th Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">322-8800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001731348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class 2 Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLRY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " !*C!%3F5R<(Q &  "<)P  $P
M            @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M $J,$5,9XL J400  .P0   8              " @0X(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " !*C!%3GZ ;\+$"  #B#   #0
M            @ &5#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $J,$5.7
MBKL<P    !,"   +              "  7$/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( $J,$5,<.&7J/P$  #P"   /              "  5H0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " !*C!%3)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " !*C!%399!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10028155_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tilray.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10028155_8k.htm">brhc10028155_8k.htm</File>
    <File>brhc10028155_ex99-1.htm</File>
    <File>tlry-20210817.xsd</File>
    <File>tlry-20210817_lab.xml</File>
    <File>tlry-20210817_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10028155_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10028155_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tlry-20210817_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tlry-20210817_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "tlry-20210817.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "tlry",
   "nsuri": "http://tilray.com/20210817",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10028155_8k.htm",
      "contextRef": "c20210817to20210817",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://tilray.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10028155_8k.htm",
      "contextRef": "c20210817to20210817",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-21-028702-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-21-028702-xbrl.zip
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MK<,IRC'!N/(;#_![R%E*1'^LU3:?7OS29,=BY>/R4;/U"7 K"<IOX-ND^1F
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MTB#/O;5E 3] #/X#LW6 )=)[@;#99_P6P5B&ZE+]F<S$CV"2<?\^FO!; "J
M,)9E%/Q): #L-D191?0N3ZP(XRTQ'<^8(IY,\Q'@W)]HQNF$Y]"(:+D)+B\K
MP]?5H$^*@;Z$2!^4,W('GI'T,19\)[>GE&[3?):;[/9KRRB[Q.+3AJ@V3/&S
M,AGE%B"KM*T7L4P]B=N% '/S<@Z"!%K !%7B"9S&4LMB4M.'TAU>-.5M T>?
M%XLGX/?[3.B-6EIG((Z,@0"95(<B4C\AWJ?9:#[K0%+$V?2A7OZ&R&(N:92!
MYX3.45#S3DF9"10L%V;7AT%"W11!,:/1/'$IN"H287BX!]].F,R4KYQBA-TJ
MU5CU@,4G"=Y;BS%X;78Q<8/5X6EK<WQ)4$53+.T*_2=X6:\\#<2E[,FQ5T<+
MDVDN4J!81F)$#4%V#2RNRQM!R14.YT5P(I$,SXL])P'($1]#P,XE%$]PXH+2
M:LIKRH3UV^/[XA&ZX/.):@B2./X[EO>9#6D:S&VO$+J'I(KC*I$?48R*61A*
M9U#(VAZ'CI?AA&?S>8[P]"R05*)9@\E/&_!DZD7<AXYCF()B2V1!=\VM_Y81
MZ(>WY_A7[/TLP+H9.%6J-9FF_HAFS>!MP>TJ0E"1;!?Q(#2WD".">+F\T#G#
MWJ I:#.;+]+)R "0!%Z&U(> 0=SPL1#.5635 [G".>"B>P@&)9HTFQ<Q*D2"
M7%@ON;A2'2:M%XSHG1R>Q(UJHT\ZC>9!*WBG% 5Z&K4)1N7JX+H1"%8>S6IL
MD&D#3(W)F\)AO);S:IF]^*T*W48L$AF9)CL.\&PID,'D*A!,>,4#3%4UO"M-
MK?JHHV4C>U!J20FW07%/X<+XR![%L%QD.*;^J"W4O&.(VC*QA6.-@SD'V#U+
M?;&6-9U 8V5G"YWL5[Q>".CO(/ 7-F^(74$K!:KGR:0[G10(5YHS%L/\BG.K
M.5 =RR3 8A92N$UC$%;A"V$)L#RX=$1Q@]==D:@D>T  L+CHCF;=:GQEIQ[-
M.+2V;,T*+@NO%XB" >6SFM#->2,Y(MK-"M&NIP=K<BK:15?*8TL9NV\9F3;D
M&[5G0(!?<UY[K":*2[K5@_E.*T4N/0[IN H$&]%;UE39/E2HN@*!\UC,0HYK
MM:!_($=@W=!,<F^*TB<2)0M][M=./B^;V9"AP8PD1!5"]BD6HBPN^,CP&@6)
ML_)T-H@Q_NX!EAL"+5!W/GH?L(O?4HE7%5U<R#BH1I)E+*M$$"PA]< Z2TN1
MLG%2C!U,_#2J3G<+-$#UO94R*H:X1'D!*$W*]^B.>&<#0(XA2\6//MR*5:.7
M<,]2B00+;NX=!7](^&&4+-+92'X()Z8Z.3^?]-6YP=+BT#++B@<9(I&SP]T^
M+$^^#%2^Z]7<S2W<ZCU%V_2ZK>#&0XNV&R'_4UP[$',#$8  @'-I N>;M'J;
M7)U]8/_B@OW9 &2L.(Y"2G5YLL'=Z,XF-(1!]6LW:#6JC0#5AK?JC@]QN4=Y
M<5[IR(LBE1"BH:Q^TJ)MA]P.C'=%;)E-!18)8!6)B8EPDY\%V9\U^5Q(GLRT
MSMU#D=HI J#"T0?_IUA=JY(YWJS:+F;LT?T]K=HPMK!+<R$AG^ !31DX%6%^
MS5G%5"./;Y-(9.)I&6"+.O#DB7+T7=N4+>\0<K>Q0^A12[.]0<U_\^NFS$M)
M9^?\?L0]T**-&IY'T.^I)\!W0X1;SX@_=MJYZ$RSMRO(G>.]8'^=T]<;$-@M
MB&SG^ $QW/CIZ+8MIRVC_CH':7UO:(G&;_4@\J90W_SJ(Y1X%C%G7608PUW8
M=RE=_X3/MH\@%Z+>*NB[=%1:;D_>\.G;!\]#/O$LE_OU9Z'7%I2=F95">L@9
MR_R43^2^JN<_V-JFHV,>!!'[@C-Y&VRK528>;FP+G)!WFNP&!H$AHT3^@*.7
MCGR =\U13?/?[-YUNVIOE(\[QZ[;4X_Z]'B7%?LIAS2W<#%,)A*!(A:5^RZ7
M?MWIV=SG9SR)TY8Y6FQ"V@G9QK+/M!Z?EW]Z+\;3=%%9"!NLGJV@H'.LMJ9F
MOY.S12]VQ<+-Q;O+D\&GZY9?QON:93;QD,?X(P. +M9D<WA8WVI=):32(B9>
M[]CL0=N)QV :S8A/I^+GMC%;*&\\QFZ\*C^$V[KA?2(76#TVHE&(R29L3]PB
M513 Q88IYAU%J_,4U]JG<;^_N,%898K7-T"MM9%.Q)4W'6U78HC!Q?OKD]\/
MR,7EZ1<D;IZ=K8^X2D]O2'E:2]OCP NX<_A#EL'AD_V/+YF6%QC=3[/#KQG*
M*L%8'0_*<]8O,M9^UB<?>.Z/ )3).]RN$/T5E/D%.(FWHVQ%;EYD-'_+Q&:.
M!^?17T@HBGMXWLD-3 1_%S3[$MGX@K"S\;E9</'5MQDX:BV!X]>,IF#A/&#\
MT@BP+9)K7B[RA"L]7I3%9(G%1WTO"6;'^&&4CR/X\%]02P,$%     @ 2HP1
M4WHG1T#A)P  ?:8  !<   !B<FAC,3 P,C@Q-35?97@Y.2TQ+FAT;>U=ZW?;
MN)7_ON?L_X#UM!W[K*3Q(\Y[<NHX3NJMDWACS\S.IQZ(A"2,28(%22N:OW[O
M P!!2G*2B5\Y;=O3R!() A<7]_[ND\]G=9Z]^,__$.+Y3,F4/L'G6M>9>O'\
M!_[7??E?PZ$XT8DJ*I6*VCP59TV>ZUJ\UH4L$BTS\4I726:JQJJ!.#DYY/OH
M/Z],TN2JJ$5BE:SA_J;2Q50<O7IS\&&B,_A<B=,/[^&C$H]'V_C?Z.Y#4RZL
MGLYJL?/DR;X8BMWMW1WQTAJ96IU.E1@.>0T_N$4\'YMT(<;3Q&3&_KCQW83^
MLR&J>I&I'S<FIJB'$YGK;/%4?'^N<U6)=VHN/IA<%M\_$_1[I7]73\7.=ED_
M$[7Z6 ]EIJ?%4Y&I"7Q#(S\5WVW3?YYM\/-3?>FI-;.B,-5,IO \]V%#T! _
M;@ -:V7#=&8*U_94/"@_+@TLQC*YF%K3%.FP_U,\*Q[RF<BEG>IBB)-\*F13
MF_"5Y8?P=V-C4P5C%:90,/GG/_B9XQ+\O.+QZ6Z\$FG3H>/<S7YLLA0N./HX
MTV/@BB=/1CO/?\ K7CP?6[<]\5/6?>U94(Z!%Q*5954I$V"0'S>V-^CO4J:I
M_YO701]7TW:NTWKV5#S:_O,R:;^4#3:$3G_<^/W1_B39&T\4L)I\\&@R>:P>
M)A*V]]$#X$JUL[_QPK-NR\+/:_LB8FCX.^W-<&__SRMW%$BN\ZFH;/+CAL[E
M5.'<=T>_E5/<MCJ]SF'W5@X+?]K>DN KW)ZK=G4]*_58U?'ESF,\:!WVY:_<
MKMGI>'-[(/!_6U^^=6(5JYX?GWPX^%4<'/[O3\<?CL[$VX/_>?_A^/Q7<?K^
M[/C\^/T[<?Q.'+P]>O?JZ)5X>_0*/HG#]^]^/OIP?OSRY$B\>W]^=-8N?YD
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M@\WHPT&)WI,H3P!)>K71'3,Q>8Y?XC@M'6!&(/MO=;OXADX.[]4A]A0C2W-
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MVGGR4."/N7'Q*4<+D<*,@[[$JM#P3%?'Y72]ER%SLL?#SOON+\XM2V%L]&8
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MU(3 X]8C%<_%:GK03+^T(W<6EDIU(R[(?SG?6>0W^2_:G_X#4$L! A0#%
M  @ 2HP14QT(D(/7%P  _(P  !,              ( !     &)R:&,Q,# R
M.#$U-5\X:RYH=&U02P$"% ,4    " !*C!%3>B='0.$G  !]I@  %P
M        @ $(&   8G)H8S$P,#(X,34U7V5X.3DM,2YH=&U02P$"% ,4
M" !*C!%3$%OF-U$#  !M#P  $0              @ $>0   =&QR>2TR,#(Q
M,#@Q-RYX<V102P$"% ,4    " !*C!%3\X0H!8$(  !R6   %0
M    @ &>0P  =&QR>2TR,#(Q,#@Q-U]L86(N>&UL4$L! A0#%     @ 2HP1
M4[6\;S;C!0  ZSX  !4              ( !4DP  '1L<GDM,C R,3 X,3=?
=<')E+GAM;%!+!08     !0 % $L!  !H4@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
